(7-054) Evaluating Vanzacaftor-Based Triple Therapy in F508del/MF Cystic Fibrosis: Insights from the SKYLINE 102 and SKYLINE 103 Trials

Tuesday, December 9, 2025

12:00 PM - 1:00 PM

Location: Bayside A, Level 1

Pharmacy School: Texas A & M University Health Science Center Irma Lerma Rangel School of Pharmacy
Pharmacy School Location: Texas

Co-Author(s): Annette De Santiago, Juan Castro, H. Stephen Lee

Primary Author(s)